Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Cadila Healthcare discloses new compounds for tuberculosis

Dec. 14, 2020

Tychan to initiate phase III study of TY-027 in patients with COVID-19

Dec. 14, 2020

Preliminary clinical data for proxalutamide in COVID-19

Dec. 14, 2020

hAd5-COVID-19 vaccine candidate protects nasal and lung airways in nonhuman primates

Dec. 14, 2020

Fera to assess naproxcinod as adjuvant treatment for patients with COVID-19

Dec. 11, 2020

TaiGen advances influenza antiviral TG-1000 into phase II study

Dec. 11, 2020

Fluvoxamine may prevent clinical deterioration in mild symptomatic COVID-19 compared with placebo

Dec. 11, 2020

Formycon reports preclinical data on FYB-207 for COVID-19

Dec. 11, 2020

Phase III VIOLET studies of oteseconazole for recurrent VVC meet primary endpoint

Dec. 10, 2020

Activity profiling and crystal structures to guide the design of SARS-CoV-2 PLpro inhibitors

Dec. 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...